Clinical trial · Interventional
Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated. However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bronchial Cancer | Bronchogenic Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ISET® - Isolation by Size of Tumor cells | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- early stage bronchial cancer
- description
- Early stage which can benefit from a surgical resection. A taking will be made in preoperative then in every consultation of follow-up after the intervention
- interventionNames
- Diagnostic Test: ISET® - Isolation by Size of Tumor cells
- type
- OTHER
- label
- advanced stage bronchial cancer
- description
- Patients locally moved forward or at a metastatic stage handled by chemotherapy
- interventionNames
- Diagnostic Test: ISET® - Isolation by Size of Tumor cells
Primary outcomes (1)
- measure
- numeration of CTC (circulant tumoral cell)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients with non-small cell lung cancer * accepting participation Exclusion Criteria: * refusing participation
References
Publications (0)
Data not yet available